Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial-mesenchymal transition and sternness

Ginsenoside Rg3 sensitizes hypoxic lung cancer cells to cisplatin via blocking of NF-κB mediated epithelial-mesenchymal transition and sternness
复制标题

人参皂苷 Rg3 通过阻断 NF-κB 介导的上皮-间质转化和干性使缺氧肺癌细胞对顺铂敏感

DOI:
10.1016/j.canlet.2017.11.037
复制
发表时间:
2018-02-28
期刊:
影响因子:
9.7
通讯作者:
Liu, Jiwei
Liu, Jiwei
中科院分区:
医学1区
文献类型:
--
作者:
Wang, Jingjing;Tian, Lili;Liu, Jiwei

文献摘要

被引文献

相似文献

顺铂是肺癌的一线化疗药物,但敏感性降低可能限制其应用。在实体瘤中,缺氧改变微环境,并与增殖、转移和药物敏感性相关。低氧诱导的顺铂脱敏作用尚未明确阐明。20(R)-人参皂苷(Rg 3)是从人参中提取的具有抗肿瘤活性的中药。在这项研究中,我们评估了Rg 3是否能有效地通过阻断缺氧来提高顺铂的敏感性。我们发现顺铂对肺癌细胞增殖的抑制作用在氯化钴(CoCl 2)诱导的缺氧中降低。缺氧引起上皮间质转化(EMT),这是检测细胞形态和EMT蛋白标记,并在干细胞球状体形成和标记分子分析的变化。缺氧还激活EMT(由核因子-κ B(NF-κ B)途径介导)和干性,Rg 3抑制NF-κ B途径的激活。此外,Rg 3可通过抑制缺氧肺癌细胞的EMT和干细胞性来增加顺铂的敏感性,并且这种作用在体内得到证实。结论:Rg 3可提高顺铂对肺癌的敏感性。(C)2017爱思唯尔B. V.保留所有权利。
Cisplatin is a first line chemotherapy in lung cancer, but decreased susceptibility may limit its application. In solid tumors, hypoxia alters the microenvironment and is associated with proliferation, metastasis, and drug sensitivity. The hypoxia-induced desensitization of cisplatin is not clearly elucidated. 20 (R)-Ginsenoside (Rg3), the traditional Chinese medicine, is extracted from ginseng and has antitumor activities. In this study, we evaluated if Rg3 is effective in improving cisplatin sensitivity by blocking hypoxia. We found that the inhibition of proliferation potential by cisplatin was reduced in cobalt chloride (CoCl2)-induced hypoxia in lung cancer cells. Hypoxia caused alterations in epithelial-mesenchymal transition (EMT), which were detected by cellular morphology and EMT protein markers, and in sternness analyzed by spheroid formation and marker molecules. Hypoxia also activated EMT, which was mediated by the nuclear factor kappa B (NF-kappa B) pathway, and sternness, and Rg3 inhibited the activation of the NF-kappa B pathway. Furthermore, Rg3 could increase the sensitivity to cisplatin by inhibiting EMT and sternness in hypoxic lung cancer cells, and this effect was confirmed in vivo. In conclusion, Rg3 may improve the sensitivity of cisplatin in lung cancer therapy. (C) 2017 Elsevier B.V. All rights reserved.